Century Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Century Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Century Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.5M, a 6.64% increase year-over-year.
  • Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.6K, a 37.1% increase from 2022.
  • Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.7K, a 99.8% decline from 2021.
  • Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.66M, a 432% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.6K +$3.95K +37.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $10.7K -$4.65M -99.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $4.66M +$3.79M +432% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $876K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.